Apricus Bio (APRI) Pops on Vitaros Marketing News
Tweet
Share
E-mailGet Alerts APRI Hot Sheet
Join SI Premium – FREE
Apricus Biosciences (Nasdaq: APRI) is seeing a pop following the announcement that its NexMed subsidiary entered a Vitaros marketing agreement in Germany.
Shares are up 5.3 percent following the news.
For more color, click here.
Shares are up 5.3 percent following the news.
For more color, click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- China Conducts Cybersecurity Review Into Palo Alto’s Products
- Lucid Group stock surges 24% on Saudi prince investment
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
